PharmaResearch Co., Ltd. (KOSDAQ:214450)
299,000
-13,000 (-4.17%)
May 27, 2026, 3:30 PM KST
PharmaResearch Market Cap
PharmaResearch has a market cap or net worth of 3.24 trillion as of May 27, 2026. Its market cap has decreased by -16.91% in one year.
Market Cap
3.24T
Enterprise Value
2.88T
Revenue
536.29B
Ranking
n/a
PE Ratio
20.89
Stock Price
299,000.00
Market Cap Chart
Since July 24, 2015, PharmaResearch's market cap has increased from 1.01T to 3.24T, an increase of 221.18%. That is a compound annual growth rate of 11.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 3.24T | -22.58% |
| Dec 30, 2025 | 4.19T | 53.52% |
| Dec 30, 2024 | 2.73T | 144.17% |
| Dec 28, 2023 | 1.12T | 60.18% |
| Dec 29, 2022 | 697.32B | -14.76% |
| Dec 30, 2021 | 818.02B | 48.15% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SK Biopharmaceuticals | 7.66T |
| HLB Co., Ltd. | 6.76T |
| Peptron | 5.98T |
| LigaChem Biosciences | 5.80T |
| Voronoi | 5.06T |
| OliX Pharmaceuticals | 3.28T |
| SK bioscience | 3.28T |
| D&D Pharmatech | 3.05T |